Hospira S.p.A.

Amended 483 issued December 6, 2022 · Liscate, Italy

Inspection
Nov 28 – Dec 6, 2022
Investigator
William Leonard
Observations
3
Pages
3
FEI number
3004640070

In short: On December 6, 2022, FDA issued a Amended 483 with 3 observations to Hospira S.p.A. in Liscate, Italy (FEI 3004640070) after an inspection that ran Nov 28 – Dec 6, 2022. The investigator was William Leonard. Most observations concern quality system and facilities & equipment.

At a glance

Quality system and facilities & equipment account for 2 of 3 observations.

Quality system1
Facilities & equipment1
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Written records of investigations into unexplained discrepancies do not include…

  2. 02

    Equipment for adequate control over micro-organisms is not provided when appropriate for the manufacture, processing, packing…

  3. 03

    The batch production and control records are deficient in that they do not include documentation of…

The full amended 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full amended 483

This inspection in context

Questions about this amended 483

What did FDA find at Hospira S.p.A.?

FDA listed 3 observations on this Form 483, mostly about quality system, facilities & equipment and production. The opening words of each observation are shown on this page.

Who inspected Hospira S.p.A.?

William Leonard is named on this Amended 483, for the inspection of Nov 28 – Dec 6, 2022. Each investigator has a profile showing what they cite most.

When was Hospira S.p.A. inspected by FDA?

The inspection ran Nov 28 – Dec 6, 2022, and the Amended 483 is dated December 6, 2022.

How do I get the full Amended 483 for Hospira S.p.A.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free